NASDAQ: SABS - SAB Biotherapeutics, Inc.

Rentabilité sur six mois: -44.84%
Secteur: Healthcare

Calendrier des promotions SAB Biotherapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases.

Plus de détails
The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development for the treatment or prevention of severe influenza. Further, the company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Sioux Falls, South Dakota.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Выручка 0.0034
EBITDA -0.0082
Число акций ао 0.00552 млрд
P/S 0.3507
P/BV 0.5539
EV/EBITDA -0.1569
Цена ао 4.17
ISIN US78397T1034
Сайт https://www.sabbiotherapeutics.com
Валюта usd
IPO date 2021-02-09
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Changement de prix par jour: -5.02% (2.5899)
Changement de prix par semaine: -7.87% (2.67)
Changement de prix par mois: -12.77% (2.82)
Changement de prix sur 3 mois: -14.29% (2.87)
Changement de prix sur six mois: -44.84% (4.46)
Changement de prix par an: +260.7% (0.682)
Evolution du prix sur 3 ans: -75.57% (10.07)
Evolution des prix depuis le début de l'année: +170.33% (0.91)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 1.75 8
P/BV 0.0684 10
P/E 0 0
EV/EBITDA 1.36 10
Total: 6

Efficacité

Nom Signification Grade
ROA, % -50.27 0
ROE, % -73.64 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.1721 10
Total: 9.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -34.15 0
Rentabilité Ebitda, % 318.66 10
Rentabilité EPS, % 3428.04 10
Total: 8
Plus de détails

Établissements Volume Partager, %
Marshall Wace LLP 4585282 49.7
RA Capital Management, L.P. 2374081 25.73
COMMODORE CAPITAL LP 1831746 19.86
RTW Investments LP 917828 9.95
BVF Inc. 917828 9.95
Sessa Capital IM, L.P. 458457 4.97
Vanguard Group Inc 99614 1.08
First Premier Bank 80754 0.88
Pathstone Holdings, LLC 50651 0.55
Geode Capital Management, LLC 35636 0.39

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
iShares Micro-Cap ETF 0.00541 43.316995205115 1.54048



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Samuel J. Reich CEO & Executive Chairman 363.2k 1975 (49 années)
Dr. Eddie Joe Sullivan Ph.D. Co-Founder, President & Director 402.56k 1966 (58 années)
Ms. Christine E. Hamilton M.B.A. Co-Founder & Independent Director 25k 1956 (68 années)
Dr. Alexandra Kropotova M.B.A., M.D. Executive VP & Chief Medical Officer 774.45k 1973 (51 année)
Dr. Edward D. Hamilton D.V.M. Co-Founder & Board Observer N/A
Dr. Christoph Bausch M.B.A., Ph.D. Executive VP & COO 443.2k 1971 (53 année)
Dr. Carlos N. Carillo Ph.D. Senior Vice President of Regulatory Affairs N/A
Mr. Mark W. Conley Interim Chief Financial Officer

Adresse: United States, Sioux Falls. SD, 2100 East 54th Street North - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.sabbiotherapeutics.com